FI118601B - Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi Download PDF

Info

Publication number: FI118601B
Authority: FI; Finland
Prior art keywords: amylin; analog; prepared; amylinagonist; pro
Prior art date: 1991-11-19

Application number

FI933252A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI933252A (fi

FI933252A0 (fi

Inventor

Howard Jones

Laura S L Gaeta

Elisabeth Albrecht

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-19

Filing date

1993-07-16

Publication date

2008-01-15

1993-07-16 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

1993-07-16 Publication of FI933252A0 publication Critical patent/FI933252A0/fi

1993-08-23 Publication of FI933252A publication Critical patent/FI933252A/fi

2008-01-15 Application granted granted Critical

2008-01-15 Publication of FI118601B publication Critical patent/FI118601B/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Immunology (AREA)
Emergency Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FI933252A 1991-11-19 1993-07-16 Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi FI118601B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US79426691A	1991-11-19	1991-11-19
US79426691		1991-11-19
US9209842		1992-11-19
PCT/US1992/009842 WO1993010146A1 (fr)	1991-11-19	1992-11-19	Peptides a action agoniste a base d'amyline et utilisations de ces peptides

Publications (3)

Publication Number	Publication Date
FI933252A0 FI933252A0 (fi)	1993-07-16
FI933252A FI933252A (fi)	1993-08-23
FI118601B true FI118601B (fi)	2008-01-15

Family

ID=25162163

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI933252A FI118601B (fi)	1991-11-19	1993-07-16	Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi

Country Status (17)

Country	Link
EP (2)	EP1162207A1 (fr)
JP (4)	JP2902115B2 (fr)
AT (1)	ATE205854T1 (fr)
AU (1)	AU714439B2 (fr)
CA (1)	CA2100745C (fr)
CZ (1)	CZ288029B6 (fr)
DE (1)	DE69232064T2 (fr)
DK (1)	DK0567626T3 (fr)
ES (1)	ES2161697T3 (fr)
FI (1)	FI118601B (fr)
GR (1)	GR3036794T3 (fr)
HK (1)	HK1041891A1 (fr)
MD (1)	MD960317A (fr)
NO (2)	NO324405B1 (fr)
RU (1)	RU2130463C1 (fr)
SK (1)	SK88793A3 (fr)
WO (1)	WO1993010146A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU222249B1 (hu)	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5625032A (en) *	1993-07-21	1997-04-29	Amylin Pharmaceuticals, Inc.	Selective amylin antagonist peptides and uses therefor
DE69426304T2 (de)	1993-09-07	2001-03-15	Amylin Pharmaceuticals Inc	Methoden zur regulation der den magen und darm betreffenden motilitaet
US6143718A (en) *	1995-06-07	2000-11-07	Amylin Pharmaceuticals, Inc.	Treatment of Type II diabetes mellutis with amylin agonists
US5739106A (en) *	1995-06-07	1998-04-14	Rink; Timothy J.	Appetite regulating compositions
US7312196B2 (en)	1997-01-08	2007-12-25	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
US6410511B2 (en)	1997-01-08	2002-06-25	Amylin Pharmaceuticals, Inc.	Formulations for amylin agonist peptides
US7101853B2 (en) *	1997-05-06	2006-09-05	Amylin Pharmaceuticals, Inc.	Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en)	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
ATE410182T1 (de) *	1998-01-09	2008-10-15	Amylin Pharmaceuticals Inc	Formulierungen für amylin peptidagonisten mit insulin
GB0128583D0 (en)	2001-11-28	2002-01-23	Rsr Ltd	Detection of autoantibodies indicative of diabetes
WO2004037168A2 (fr)	2002-10-18	2004-05-06	Amylin Pharmaceuticals, Inc.	Traitement de la pancreatite avec de l'amyline
WO2004083243A1 (fr) *	2003-03-18	2004-09-30	Applied Research Systems Ars Holding N.V.	Inhibiteurs d'agregation d'amyline et utilisation desdits inhibiteurs.
EP1807442A1 (fr) *	2004-10-26	2007-07-18	Lonza Ag	Groupements protecteurs s-alkyl-sulphenyl pour synthese en phase solide
US8394765B2 (en)	2004-11-01	2013-03-12	Amylin Pharmaceuticals Llc	Methods of treating obesity with two different anti-obesity agents
EP2286838A3 (fr)	2004-11-01	2013-09-04	Amylin Pharmaceuticals, LLC	Traitement de l'obésité et de maladies liés à l'obésité
EA013121B1 (ru)	2005-03-31	2010-02-26	Амилин Фармасьютикалз, Инк.	Амилин и агонисты амилина для лечения психиатрических заболеваний и расстройств
US8168592B2 (en)	2005-10-21	2012-05-01	Amgen Inc.	CGRP peptide antagonists and conjugates
JP2010502670A (ja)	2006-09-07	2010-01-28	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	真性糖尿病のための組合せ治療
EP2120985B1 (fr)	2007-02-05	2012-06-27	Amylin Pharmaceuticals, Inc.	FN-38 peptides pour son utilisation dans le traitement des maladies psychotiques et des troubles anxieux
JP2009149684A (ja) *	2009-03-11	2009-07-09	Amylin Pharmaceut Inc	アミリン作動薬ペプチド用製剤
KR101673042B1 (ko)	2009-03-12	2016-11-04	키바이오사이언스 아게	당뇨병 및 대사 증후군의 치료
AR097701A1 (es) *	2013-09-19	2016-04-13	Zealand Pharma As	Análogos de amilina
CA2928725A1 (fr)	2013-11-05	2015-05-14	Esther Priel	Composes pour le traitement du diabete et des complications pathologiques qui en resultent
DK3137494T3 (da) *	2014-05-02	2021-10-04	Univ New York State Res Found	Isletamyloidpolypeptider med forbedret opløselighed
EA035791B1 (ru)	2015-03-18	2020-08-11	Зилэнд Фарма А/С	Аналоги амилина
US10071140B2 (en)	2016-09-09	2018-09-11	Zealand Pharma A/S	Amylin analogues
WO2018144671A1 (fr)	2017-02-01	2018-08-09	The Research Foundation For The State University Of New York	Polypeptides à îlots amyloïdes mutants présentant une solubilité améliorée et leurs procédés d'utilisation
KR102130354B1 (ko) *	2019-08-14	2020-07-06	엘아이지넥스원 주식회사	코어 제거용 이형장치
AU2023278353A1 (en)	2022-05-30	2024-05-23	Zealand Pharma A/S	Liquid formulations of amylin analogues
WO2024061919A1 (fr)	2022-09-19	2024-03-28	Zealand Pharma A/S	Polythérapie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
WO1989006135A1 (fr) *	1988-01-11	1989-07-13	Amylin Corporation	Traitement du diabete sucre du type 2
WO1991000737A1 (fr) *	1989-07-10	1991-01-24	Amylin Corporation	Traitement de l'obesite et de l'hypertension essentielle ainsi que des troubles associes
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
WO1992015317A1 (fr) *	1991-03-08	1992-09-17	Amylin Pharmaceuticals, Inc.	Preparation synthetique d'amyline et d'analogues d'amyline

1992
- 1992-11-19 MD MD96-0317A patent/MD960317A/ro unknown
- 1992-11-19 DK DK92924442T patent/DK0567626T3/da active
- 1992-11-19 CZ CZ19931689A patent/CZ288029B6/cs not_active IP Right Cessation
- 1992-11-19 EP EP01114132A patent/EP1162207A1/fr not_active Ceased
- 1992-11-19 EP EP92924442A patent/EP0567626B1/fr not_active Expired - Lifetime
- 1992-11-19 JP JP5509441A patent/JP2902115B2/ja not_active Expired - Lifetime
- 1992-11-19 WO PCT/US1992/009842 patent/WO1993010146A1/fr active IP Right Grant
- 1992-11-19 RU RU93053497A patent/RU2130463C1/ru active
- 1992-11-19 CA CA002100745A patent/CA2100745C/fr not_active Expired - Lifetime
- 1992-11-19 SK SK887-93A patent/SK88793A3/sk unknown
- 1992-11-19 ES ES92924442T patent/ES2161697T3/es not_active Expired - Lifetime
- 1992-11-19 AT AT92924442T patent/ATE205854T1/de active
- 1992-11-19 DE DE69232064T patent/DE69232064T2/de not_active Expired - Lifetime
1993
- 1993-07-16 FI FI933252A patent/FI118601B/fi not_active IP Right Cessation
- 1993-07-19 NO NO19932603A patent/NO324405B1/no not_active IP Right Cessation
1997
- 1997-01-31 AU AU12456/97A patent/AU714439B2/en not_active Expired
1998
- 1998-09-30 JP JP10277573A patent/JPH11152299A/ja not_active Withdrawn
2001
- 2001-10-04 GR GR20010401656T patent/GR3036794T3/el unknown
2002
- 2002-05-02 HK HK02103291.8A patent/HK1041891A1/zh unknown
2003
- 2003-01-15 JP JP2003007228A patent/JP2003238594A/ja not_active Withdrawn
2006
- 2006-02-03 JP JP2006027334A patent/JP4018116B2/ja not_active Expired - Lifetime
2007
- 2007-06-25 NO NO20073265A patent/NO20073265L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ168993A3 (en)	1994-04-13
CA2100745C (fr)	2007-07-31
HK1041891A1 (zh)	2002-07-26
EP0567626A1 (fr)	1993-11-03
JP2003238594A (ja)	2003-08-27
DE69232064D1 (de)	2001-10-25
DK0567626T3 (da)	2001-12-17
NO932603D0 (no)	1993-07-19
JP2006213716A (ja)	2006-08-17
JP2902115B2 (ja)	1999-06-07
NO324405B1 (no)	2007-10-08
JPH06504794A (ja)	1994-06-02
AU1245697A (en)	1997-03-27
ATE205854T1 (de)	2001-10-15
ES2161697T3 (es)	2001-12-16
AU3075392A (en)	1993-06-15
EP1162207A1 (fr)	2001-12-12
GR3036794T3 (en)	2002-01-31
CA2100745A1 (fr)	1993-05-20
JPH11152299A (ja)	1999-06-08
NO20073265L (no)	1993-09-17
FI933252A (fi)	1993-08-23
RU2130463C1 (ru)	1999-05-20
AU714439B2 (en)	2000-01-06
FI933252A0 (fi)	1993-07-16
WO1993010146A1 (fr)	1993-05-27
JP4018116B2 (ja)	2007-12-05
CZ288029B6 (cs)	2001-04-11
MD960317A (ro)	1998-05-31
SK88793A3 (en)	1994-12-07
DE69232064T2 (de)	2002-03-28
NO932603L (no)	1993-09-17
EP0567626B1 (fr)	2001-09-19
AU673147B2 (en)	1996-10-31

Legal Events

Date

Code

Title

Description

2008-01-15

FG

Patent granted

Ref document number: 118601

Country of ref document: FI

2012-12-10

PC

Transfer of assignment of patent

Owner name: AMYLIN PHARMACEUTICALS, LLC

Owner name: ASTRAZENECA PHARMACEUTICALS LP

2012-12-20

MA

Patent expired

Publication	Publication Date	Title
FI118601B (fi)	2008-01-15	Menetelmä terapeuttisesti käyttökelpoisen amyliiniagonistianalogin tai sen suolan valmistamiseksi
US5686411A (en)	1997-11-11	Amylin agonist peptides and uses therefor
USRE40850E1 (en)	2009-07-14	Analogs of parathyroid hormone
US7410948B2 (en)	2008-08-12	Analogs of parathyroid hormone
EP1405861B1 (fr)	2009-09-09	Analogues de l'hormone parathyroide
US5847066A (en)	1998-12-08	Analogs of growth hormone-releasing factor
EP1645566A2 (fr)	2006-04-12	Analogues de l'hormone parathyroide
AU673147C (en)	1998-04-23	Amylin agonist peptides and uses therefor
CA2226177C (fr)	2010-09-07	Analogues de la parathormone
CZ85393A3 (en)	1994-03-16	Stabilized active analogs of growth hormone releasing factors
PL191239B1 (pl)	2006-04-28	Peptydy, analogi hormonu przytarczyc